LBI-HTA - Publications - Search - Year: 2013
Number of items: 31.

Krüger, L.J. and Wild, C. (2013): Evidence requirements for the authorization and reimbursement of high-risk medical devices in the USA, Europe, Australia and Canada: An analysis of seven high-risk medical devices. HTA-Projektbericht 73.

Breuer, J. and Nachtnebel, A. (2013): Afatinib (Giotrif®) for the treatment of EGFR TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s). DSD: Horizon Scanning in Oncology 41.

Zechmeister-Koss, I. (2013): Zostavax® for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA Core Model for Rapid Relative Effectiveness Assessment. Pilot-ID: WP-SA-1. Decision Support Document 73.

Wild, C. and Hintringer, K. and Narath, M. (2013): Hadron therapy: Proton and carbon ion therapy - A review of clinical evidence of efficacy, ongoing research and reimbursement. HTA-Projektbericht 74.

Reinsperger, I. and Patera, N. and Piso, B. (2013): Treatment by clinical psychologists. Part II: Literature overview on methods of treatment and areas of application. HTA-Projektbericht 69b.

Patera, N. and Reinsperger, I. (2013): Treatment by clinical psychologists. Part I: Overview of training requirements and systematic stakeholder analysis on delineation of areas of responsibility and treatment methods. HTA-Projektbericht 69a.

Semlitsch, T. and Zengerer, A. and Jeitler, K. (2013): Dabrafenib (Tafinlar®) in previously untreated subjects with BRAF mutation-positive advanced (stage III) or metastatic (stage IV) melanoma. DSD: Horizon Scanning in Oncology 42.

Breuer, J. and Piso, B. (2013): Occupational therapy in children and adolescents. Literature review on indications, utilisation and recommendations. HTA-Projektbericht 70.

Winkler, R. and Piso, B. (2013): Mental Health Rehabilitation for Children and Adolescents – Systematic overview of evaluation outcomes and instruments. HTA-Projektbericht 67.

Mayer, J. and Nachtnebel, A. (2013): Identification of ineffective interventions and technologies: Existing models and their implementation. HTA-Projektbericht 68.

Kisser, A. and Zechmeister-Koss, I. (2013): P16/Ki-67 Dual Stain in the triage of PAPIII/IIID cytology in cervical cancer screening . HTA-Projektbericht 72.

Nachtnebel, A. (2013): Pomalidomide (Pomalidomide Celgene/Pomalyst®) for the ≥ 3rd-line therapy of patients with relapsed and refractory multiple myeloma. DSD: Horizon Scanning in Oncology 39.

Rothschedl, E. and Nachtnebel, A. (2013): Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC). DSD: Horizon Scanning in Oncology 40.

Fischer, S. and Zechmeister-Koss, I. and Huic, M. (2013): Duodeno-jejunal bypass liner (DJBL) for patients with obesity, with/without type 2 diabetes mellitus . Decision Support Document 67.

Rothschedl, E. and Nachtnebel, A. (2013): Aflibercept (Zaltrap®) in addition to FOLFIRI for the 2nd line therapy of metastatic colorectal cancer. DSD: Horizon Scanning in Oncology 38.

Breuer, J. and Nachtnebel, A. (2013): Enzalutamide (Xtandi®) for patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy . DSD: Horizon Scanning in Oncology 37.

Nachtnebel, A. and Polkowska, M. and Czeczot , J. and Joppi, R. and Poggiani, C. (2013): Trastuzumab emtansine (Kadcyla™) for previously treated patients with HER2-positive advanced/metastatic breast cancer . DSD: Horizon Scanning in Oncology 36.

Fried, A. and Wild, C. (2013): Hybrid operating room. Rapid Assessment 006.

Zechmeister-Koss, I. and Nachtnebel, A. (2013): Implantation of a lumbar artificial endoprosthesis (anuloplasty/anular repair device). Decision Support Document 65.

Hintringer, K. and Warmuth, M. (2013): Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013. Decision Support Document 24/ Update 2013.

Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.

Stumpner, T. (2013): Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks. Decision Support Document 70.

Nachtnebel, A. and Warmuth, M. (2013): Percutaneous coronary intervention for chronic total occlusion. Decision Support Document 64.

Warmuth, M. and Stumpner, T. (2013): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB). Decision Support Document 68.

Warmuth, M. (2013): Endovascular repair of aortic aneurysms. Decision Support Document 69.

Reinsperger, I. and Winkler, R. and Piso, B. (2013): Re-orientation of the Austrian parent-child preventive care programme. Part IX: Recommendations from evidence-based guidelines for screening measures during pregnancy and early childhood (0-6 yrs.) . HTA-Projektbericht 62.

Semlitsch , T. and Jeitler, K. (2013): Crizotinib (Xalkori®) for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) . DSD: Horizon Scanning in Oncology 35.

Wild, C. (2013): Repair of cartilage defects via matrix-associated autologous chondrocyte immigration. Decision Support Document 66.

Wild, C. and Blagojevic, S. (2013): Annual Report 2012.

Patera, N. (2013): Screening for Colorectal Cancer. Part 3: Status of screening-activities and quality assurance of screening-colonoscopy. HTA-Projektbericht 41c.

Van der Vossen, A. (2013): Marketing Authorisations under Exceptional Circumstances for Oncology Drugs . HTA- Projektbericht 65.

This list was generated on Wed Nov 22 17:00:05 2017 CET.